The global pest control industry is witnessing steady growth as rodent infestations continue to pose significant threats to agriculture, food storage, and public health. At the core of this defense stands the Rodenticides Market, where anticoagulant formulations have established themselves as the dominant product type due to their broad regulatory approval and proven efficacy. As per Market Research Future, the Rodenticides Market reached an estimated USD 6.48 Billion in 2025 and is projected to grow from USD 6.78 Billion in 2026 to USD 10.08 Billion by 2035, registering a compound annual growth rate (CAGR) of 4.50% across the forecast period. Central to this growth trajectory is the sustained demand for anticoagulant rodenticides efficacy, which commanded 60.8% of the market share in 2025.

Anticoagulant rodenticides remain the backbone of the Rodenticides Market, with first-generation compounds like warfarin used in residential settings and second-generation products such as brodifacoum and bromadiolone deployed in commercial environments. These products work by preventing blood clotting, leading to internal bleeding and eventual death. Their widespread adoption is driven by their established efficacy profiles, broad regulatory approval across major markets, and the availability of effective antidotes (Vitamin K1) that make them safer for use around humans and non-target animals when applied correctly.

The dominance of anticoagulant rodenticides is being reinforced by the need for proven, reliable solutions in critical sectors. FAO assessments indicate that rodents destroy 5–10% of global cereal harvests annually, sharpening policy focus on crop-protection investment. Stringent food-safety mandates under Codex Alimentarius guidelines and tightened USDA and EPA sanitation standards in North America continue to drive demand for effective, compliant rodent control measures. While regulatory pressure on second-generation anticoagulants is increasing in some regions, their established role in professional pest management ensures they will remain a cornerstone of the market throughout the forecast period.

FAQs:

Q1: Why are anticoagulant rodenticides the most widely used type in the market?
A: Anticoagulant rodenticides are the most widely used due to their proven efficacy, broad regulatory approval, established safety profile with an effective antidote (Vitamin K1), and availability in various formulations suitable for different application environments.

Q2: What is the projected CAGR for the Rodenticides Market through 2035?
A: The Rodenticides Market is projected to register a CAGR of 4.50% from 2026 to 2035, reaching approximately USD 10.08 Billion by 2035.